A phase II, open label trial in treatment naive, HIV 1 infected subjects who will receive TMC114/Rtv as a monotherapy

Trial Profile

A phase II, open label trial in treatment naive, HIV 1 infected subjects who will receive TMC114/Rtv as a monotherapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2010

At a glance

  • Drugs Darunavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 24 Apr 2008 Status changed from in progress to discontinued, reported by ClinicalTrials.gov. The study was terminated due to poor recruitment.
    • 24 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top